中國汽車內飾(00048.HK)完成配售7166.36萬股 淨籌2230萬港元
格隆匯 5 月 3日丨中國汽車內飾(00048.HK)宣佈,配售事項的所有條件均已獲達成,而配售事項於2021年5月3日完成。配售代理已成功配售合共7166.36萬股配售股份予不少於六名承配人,配售價為每股配售股份0.32港元,相當於經擴大後公司已發行股本約42.86%。
配售事項的所得款項總額及淨額分別為約2290萬港元及約2230萬港元。預期配售事項的所得款項淨額將用於:(i)約1030萬港元用於償還銀行借款;及(ii)約1200萬港元用於新生產線的安裝及其一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.